Le Lézard
Classified in: Health
Subjects: CCA, TDS, FVT

Johnson & Johnson to Participate in the Goldman Sachs 39th Annual Global Healthcare Conference


NEW BRUNSWICK, N.J., May 29, 2018 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) will participate in the Goldman Sachs 39th Annual Global Healthcare Conference on Tuesday, June 12, at the Terranea Resort in Rancho Palos Verdes, California.  Tom Cavanaugh, President, Oncology, Janssen Pharmaceuticals and Scott White, President, Immunology will represent the Company in a session scheduled at 9:20 a.m. (Pacific Time).

This webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at www.investor.jnj.com.

A webcast and podcast replay will be available approximately two hours after the live webcast.

(PRNewsfoto/Johnson & Johnson)

 

SOURCE Johnson & Johnson


These press releases may also interest you

at 00:01
U.S. News Announces 2024 Best Senior Living Ratings
U.S. News & World Report, the global authority in hospital rankings and consumer advice, today revealed its 2024 Best Senior Living ratings to assist seniors and their families with researching and choosing the best senior living community for their...

15 avr 2024
Spravato® Therapy at Hudson Mind Ushers in New Era of Accessible Care for Treatment-Resistant Depression
Hudson Mind, an interventional mental health clinic in New York City, announces the addition of Spravato® (https://mind.hudson.health/treatments/spravato/). The integration of Spravato opens the door to more accessible treatment options for patients...

15 avr 2024
Active Nutraceuticals Ingredients Market Projected to Reach $392.58 billion by 2030 - Exclusive Report by 360iResearch
The report titled "Active Nutraceuticals Ingredients Market by Type (Carotenoids, Fibers & Specialty Carbohydrates, Minerals), Form (Dry, Liquid), Health Benefit, Application, Distribution Channel - Global Forecast 2024-2030" is now available on...

15 avr 2024
Multicancer Screening Market Projected to Reach $2.72 billion by 2030 - Exclusive Report by 360iResearch
The report titled "Multicancer Screening Market by Product (AI and Machine Learning-Based Platforms, Blood-Based Tests, Breath Analysis Tests), Test Type (In-vitro diagnostics, Laboratory Developed Tests), Technology, Cancer Type, End User - Global...

15 avr 2024
Allozymes Expands Global Footprint, Establishes European Subsidiary to Fuel Bioeconomy Advancement
Allozymes, a leading innovator in enzyme discovery and engineering for the food and chemical industries, is announcing the establishment of its European subsidiary in Toulouse, France. This strategic move marks a significant expansion of Allozymes'...

15 avr 2024
Nebulizer Market Projected to Reach $3.97 billion by 2030 - Exclusive Report by 360iResearch
The report titled "Nebulizer Market by Type (Jet Nebulizer, Mesh Nebulizer, Ultrasonic Nebulizer), Distribution Channel (Offline, Online), Application, End-user - Global Forecast 2024-2030" is now available on 360iResearch.com's offering, presents an...

More news about Health...


News published on and distributed by: